Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Summary Review
  • Published:

Can tissue biomarkers be used to determine the prognosis of oral leukoplakia lesions with regards to malignant transformation?

Evidence-Based Dentistry volume 23, pages 18–19 (2022)Cite this article

Abstract

Design Systematic review looking at published studies which aimed to identify human tissue biomarkers which could predict malignant transformation of oral leukoplakia (OL) lesions.

Case/control selection Articles were identified from PubMed, EBSCO and Cochrane library databases using combinations of keywords. Randomised clinical trials, case-control studies and prospective and retrospective cohort studies were included. All studies had to include follow-up data. There were no restrictions regarding gender, age groups, geographic origin, or year of publication. The selection process involved two of the researchers independently analysing titles and abstracts to identify articles for full-text reading. The same authors then read the articles identified for full-text reading, applying the eligibility criteria. If there was a disagreement with regards to the selection, a discussion was had until a consensus was reached.

Data analysis Qualitative data was presented as reported from the primary studies. Quantitative analysis was not carried out due to the high heterogeneity across the studies.

Results Forty-six studies were included within the systematic review. These studies identified a total of 3,783 patients with OL, of which 1,047 went on to develop oral cancer, giving an average malignant transformation incidence of 27.6%. Forty-nine different tissue biomarkers were evaluated among the included studies, with the p53 and podoplanin proteins and loss of heterozygosity the most frequently discussed.

Conclusions Of the biomarkers studied, podoplanin and chromosomal loci abnormalities (such as loss of heterozygosity) would appear the most promising in being able to predict malignant transformation of OL lesions; however, further research is required.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Mello F W, Miguel A F P, Dutra K L et al. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med 2018; 47: 633-640.

  2. Aguirre-Urizar J M, Lafuente-Ibáñez de Mendoza I, Warnakulasuriya S. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years. Oral Dis 2021; 27: 1881-1895.

  3. Van der Waal I. Oral potentially malignant disorders: is malignant transformation predictable and preventable? Med Oral Patol Oral Cir Bucal 2014; DOI: 10.4317/medoral.20205.

  4. Wang T, Wang L, Yang H et al. Development and validation of nomogram for prediction of malignant transformation in oral leukoplakia: A large-scale cohort study. J Oral Pathol Med 2019; 48: 491-498.

  5. Frame S, Crombie R, Liddell J et al. Epithelial carcinogenesis in the mouse: correlating the genetics and the biology. Philos Trans R Soc Lond B Biol Sci 1998; 353: 839-845.

  6. Warnakulasuriya S, Kovacevic T, Madden P et al. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England. J Oral Pathol Med 2011; 40: 677-683.

  7. Kujan O, Khattab A, Oliver R J, Roberts S A, Thakker N, Sloan P. Why oral histopathology suffers inter-observer variability on grading oral epithelial dysplasia: An attempt to understand the sources of variation. Oral Oncol 2007; 43: 224-231.

  8. Odell E W. Aneuploidy and loss of heterozygosity as risk markers for malignant transformation in oral mucosa. Oral Dis 2021; 27: 1993-2007.

Download references

Author information

Authors and Affiliations

  1. Speciality Dentist in Oral Medicine, Glasgow Dental Hospital, Glasgow, UK

    Matthew Cousins

  2. Dental Core Trainee 2 in Oral and Maxillofacial Surgery, Queen Elizabeth University Hospital, Glasgow, UK

    Kirsty Carney

Authors
  1. Matthew Cousins
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kirsty Carney
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cousins, M., Carney, K. Can tissue biomarkers be used to determine the prognosis of oral leukoplakia lesions with regards to malignant transformation?. Evid Based Dent 23, 18–19 (2022). https://doi.org/10.1038/s41432-022-0254-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41432-022-0254-y

Search

Advanced search

Quick links